QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer
Clinical trial NCT07342283 · RECRUITING
Trial details
- NCT number
- NCT07342283
- Sponsor
- Affiliated Hospital of Nantong University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-25
- Primary completion
- 2027-12-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.